Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Generics (UK) Ltd t/a Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Ezinelle 1.5 mg tablet.
| Pharmaceutical Form |
|---|
|
Tablet. The tablet is a round, white to off-white, uncoated flat tablet debossed ‘145’ on one side and plain on the other side. |
Each tablet contains 1.5 mg of levonorgestrel.
Excipient with known effect:
Each tablet contains 154 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levonorgestrel |
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
| List of Excipients |
|---|
|
Povidone K-25 |
Blister composed of PVC film coated with PVDC and aluminium foil.
Pack size: 1 tablet.
Generics (UK) Ltd t/a Mylan, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 04569/1486
13/05/2015
| Drug | Countries | |
|---|---|---|
| EZINELLE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
